H. Samaratunga

Brett Hemamali David J. Andrew J. Daniel M. Chin-Chen Gl Delahunt Samaratunga Grignon Evans Berney P, G. Litjens, J. A. van der Laak, 2020, Modern Pathology.

Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.

H. Samaratunga, J. Clements, Y. Dong, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Evidence for steroidogenic potential in human prostate cell lines and tissues.

David W. Johnson, H. Samaratunga, Tao Yang, 2012, The American journal of pathology.

Decreased apoptosis repressor with caspase recruitment domain confers resistance to sunitinib in renal cell carcinoma through alternate angiogenesis pathways.

David W. Johnson, H. Samaratunga, R. Rajandram, 2016, Biochemical and biophysical research communications.

Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker

H. Samaratunga, R. Gardiner, R. Scott, 2018, Nature Communications.

Grading of renal cell carcinoma

B. Delahunt, H. Samaratunga, L. Egevad, 2018, Histopathology.

Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer.

J. Logan, B. Delahunt, H. Samaratunga, 2022, Pathology.

Ductal adenocarcinoma of the prostate: current opinion and controversies.

B. Delahunt, H. Samaratunga, 2008, Analytical and quantitative cytology and histology.

A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer

H. Samaratunga, J. Batra, P. Heathcote, 2018, Scientific Reports.

Expression of the Disintegrin Metalloprotease, ADAM-10, in Prostate Cancer and Its Regulation by Dihydrotestosterone, Insulin-Like Growth Factor I, and Epidermal Growth Factor in the Prostate Cancer Cell Model LNCaP

H. Samaratunga, D. McCulloch, A. Herington, 2004, Clinical Cancer Research.

Cerebral metastasis of an atrial myxoma mimicking an epithelioid hemangioendothelioma.

H. Samaratunga, J. Searle, D. Cominos, 1994, The American journal of surgical pathology.

Ductal adenocarcinoma of the prostate—reply

B. Delahunt, H. Samaratunga, J. Yaxley, 2011 .

LOT and HOT … or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia.

B. Delahunt, G. Kristiansen, Katia R. M. Leite, 2022, Pathology.

Multifocal Primary Neoplasms in Kidney Allografts: Evaluation of Two Cases

H. Samaratunga, G. Gobe, S. Wood, 2016, Journal of kidney cancer and VHL.

Datasets for the reporting of neoplasia of the testis: recommendations from the International Collaboration on Cancer Reporting

D. Berney, H. Samaratunga, J. Srigley, 2018, Histopathology.

Recently described and unusual variants of urothelial carcinoma of the urinary bladder.

B. Delahunt, H. Samaratunga, 2012, Pathology.

Phyllodes tumors of the breast: Correlation of nucleolar organizer regions with histopathological malignancy grading, flow cytometric DNA analysis and clinical outcome

H. Samaratunga, C. Swanson, B. Clarke, 2001, Pathology international.

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy

P. Ström, B. Delahunt, H. Samaratunga, 2020, Journal of Clinical Pathology.

Use of the ISUP e-learning module improves interrater reliability in prostate cancer grading

B. Delahunt, T. H. van der Kwast, H. Samaratunga, 2022, Journal of clinical pathology.

Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease.

H. Samaratunga, C. Nelson, P. Russell, 2016, Pathology.

Estimating diagnostic uncertainty in artificial intelligence assisted pathology using conformal prediction

P. Ruusuvuori, B. Delahunt, H. Samaratunga, 2022, Nature communications.

A Working Group Classification of Focal Prostate Atrophy Lesions

Ximing J. Yang, M. Loda, M. Rubin, 2006, The American journal of surgical pathology.

A new lyssavirus — fhe first endemic rabies-related virus recognized in Australia

H. Samaratunga, A. Gould, A. Hyatt, 1997 .

Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients

H. Samaratunga, A. Vargas, H. Moch, 2021, Modern Pathology.

Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)

H. Samaratunga, M. Lavin, B. Fogel, 2019, The Cerebellum.

Tumour-like lesions of the urinary bladder.

B. Delahunt, H. Samaratunga, L. Egevad, 2020, Pathology.

Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)

H. Samaratunga, J. Clements, A. Ramsay, 2008, Biological chemistry.

Dataset for the reporting of urinary tract carcinoma—biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR)

B. Delahunt, D. Grignon, T. H. van der Kwast, 2019, Modern Pathology.

Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR)

B. Delahunt, H. Samaratunga, J. Srigley, 2019, Histopathology.

Localization of N-acetyltransferases NAT1 and NAT2 in human tissues.

H. Samaratunga, D. Grant, A. Gaedigk, 2000, Toxicological sciences : an official journal of the Society of Toxicology.

Immunohistochemical profile of ductal adenocarcinoma of the prostate

B. Delahunt, H. Samaratunga, J. Lindberg, 2014, Virchows Archiv.

Mesenchymal tumors of adult kidney.

B. Delahunt, H. Samaratunga, 2015, Seminars in diagnostic pathology.

Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation.

B. Delahunt, H. Samaratunga, N. Dunglison, 2012, Anticancer research.

Update on Urinary Bladder Pathology : Recently described and unusual tumors of the urinary bladder

H. Samaratunga, 2012 .

Perithyroidal Salivary Gland Acinic Cell Carcinoma: Morphological and Molecular Attributes of a Unique Lesion

B. Delahunt, H. Samaratunga, L. Egevad, 2020, Head and Neck Pathology.

New Genomic Structure for Prostate Cancer Specific Gene PCA3 within BMCC1: Implications for Prostate Cancer Detection and Progression

Zhongming Zhao, Robert A. Gardiner, Raymond A. Clarke, 2009, PloS one.

Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations.

B. Delahunt, G. Kristiansen, H. Samaratunga, 2018, Pathology.

Genetic profile of ductal adenocarcinoma of the prostate.

B. Delahunt, H. Samaratunga, J. Lindberg, 2017, Human pathology.

What is the molecular pathology of low-risk prostate cancer?

H. Samaratunga, J. Epstein, 2008, World Journal of Urology.

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study

Robert A Gardiner, Rob Carter, Suzanne K Chambers, 2016, The Lancet.

Pleomorphic giant cell carcinoma of the urinary bladder: an extreme form of tumour de‐differentiation

B. Delahunt, H. Samaratunga, L. Egevad, 2016, Histopathology.

Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens

B. Delahunt, J. Kench, H. Samaratunga, 2011, Pathology.

Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2

J. Kench, H. Samaratunga, J. Fu, 2015, Pathology.

Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists

B. Delahunt, D. Berney, D. Grignon, 2014, Histopathology.

Use of multiple biomarkers for a molecular diagnosis of prostate cancer

Robert A Gardiner, H. Samaratunga, R. Gardiner, 2005, International journal of cancer.

Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin

B. Delahunt, H. Samaratunga, J. Lindberg, 2022, The Prostate.

Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.

B. Delahunt, A. Evans, J. Kench, 2019, Pathology.

Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis

H. Samaratunga, C. Porta, A. Scarpa, 2016, Targeted Oncology.

Pathology of the renal pelvis and ureter

B. Delahunt, H. Samaratunga, 2013 .

Expression analysis of δ‐catenin and prostate‐specific membrane antigen: Their potential as diagnostic markers for prostate cancer

H. Samaratunga, J. Clements, R. Gardiner, 2002, International journal of cancer.

Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial

B. Delahunt, H. Samaratunga, J. Srigley, 2020, Histopathology.

Renal Cell Neoplasms of Oncocytosis Have Distinct Morphologic, Immunohistochemical, and Cytogenetic Profiles

B. Delahunt, D. Grignon, H. Samaratunga, 2010, The American journal of surgical pathology.

Gleason grading: past, present and future

Brett Delahunt, B. Delahunt, A. Evans, 2012, Histopathology.

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge

Po-Hsuan Cameron Chen, David F. Steiner, G. Corrado, 2022, Nature Medicine.

Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists

Daan Nieboer, Liang Cheng, Lars Egevad, 2016, Histopathology.

Percutaneous renal tumour biopsy

B. Delahunt, A. Evans, H. Samaratunga, 2014, Histopathology.

Les tumeurs rénales: Recommandations de la conférence de consensus de I'International Society of Urologic Pathology (ISUP) 2012

J. Cheville, B. Delahunt, P. Humphrey, 2014 .

Handling and Staging of Renal Cell Carcinoma: The International Society of Urological Pathology Consensus (ISUP) Conference Recommendations

B. Delahunt, D. Grignon, H. Samaratunga, 2013, The American journal of surgical pathology.

Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features.

B. Delahunt, H. Samaratunga, L. Egevad, 2016, Pathology.

Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension.

B. Delahunt, H. Samaratunga, J. Yaxley, 2010, Human pathology.

A novel technique for biobanking of large sections of radical prostatectomy specimens

B. Delahunt, H. Samaratunga, J. Lindberg, 2018, Histopathology.

A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma

Anne Bernard, Nicholas Saunders, H. Samaratunga, 2016, Journal of Clinical Pathology.

Primary lymphoma of pituitary gland: A neoplasm of acquired malt?

H. Samaratunga, D. Perry-Keene, R. Apel, 1997, Endocrine pathology.

Cellular angiofibroma of the scrotum.

H. Samaratunga, P. Fitzpatrick, 2008, Pathology.

Human papillomavirus DNA in glandular lesions of the uterine cervix.

H. Samaratunga, R. G. Wright, N. Cox, 1993, Journal of clinical pathology.

International Society of Urological Pathology (ISUP) grading of prostate cancer – An ISUP consensus on contemporary grading

B. Delahunt, H. Samaratunga, J. Srigley, 2016, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Genetic Association of the KLK4 Locus with Risk of Prostate Cancer

H. Samaratunga, A. Spurdle, S. Chambers, 2012, PloS one.

Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms.

H. Samaratunga, J. Clements, R. Gardiner, 2005, Endocrine-related cancer.

Effective maybe, but is it cost‐effective? A reply

B. Delahunt, H. Samaratunga, J. Nacey, 2014, Histopathology.

The ISUP system of staging, grading and classification of renal cell neoplasia

B. Delahunt, H. Samaratunga, T. Gianduzzo, 2014, Journal of kidney cancer and VHL.

Grading of Clear Cell Renal Cell Carcinoma Should be Based on Nucleolar Prominence

B. Delahunt, H. Samaratunga, J. Srigley, 2011, The American journal of surgical pathology.

Initial multicentre experience of 68gallium‐PSMA PET/CT guided robot‐assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited

H. Samaratunga, P. Stricker, W. Delprado, 2017, BJU international.

Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques

B. Delahunt, H. Samaratunga, J. Srigley, 2017, World Journal of Urology.

H. Samaratunga, J. Clements, N. Bock, 2017, Molecular oncology.

Loss of Heterozygosity at the BRCA2 Locus Detected by Multiplex Ligation-Dependent Probe Amplification is Common in Prostate Cancers from Men with a Germline BRCA2 Mutation

H. Samaratunga, J. Hopper, S. Dawson, 2008, Clinical Cancer Research.

Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist

M. Rubin, A. Chinnaiyan, B. Delahunt, 2014, Virchows Archiv.

Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker

H. Samaratunga, R. Gardiner, R. Scott, 2018, Nature Communications.

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study.

H. Samaratunga, S. Chambers, S. Occhipinti, 2018, The Lancet. Oncology.

A case of rabies

H. Samaratunga, J. Faoagali, G. Strutton, 1988, The Medical journal of Australia.

Data Set for the Reporting of Carcinoma of the Renal Pelvis and Ureter—Nephroureterectomy and Ureterectomy Specimens

B. Delahunt, T. H. van der Kwast, H. Samaratunga, 2019, The American journal of surgical pathology.

Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?

H. Samaratunga, S. D. Vecchio, R. Rajandram, 2018, Pathology.

Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsies

P. Ruusuvuori, P. Ström, H. Olsson, 2021, Virchows Archiv.

A novel transcript from the KLKP1 gene is androgen regulated, down‐regulated during prostate cancer progression and encodes the first non‐serine protease identified from the human kallikrein gene locus

H. Samaratunga, J. Clements, R. Gardiner, 2008, The Prostate.

Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer

H. Samaratunga, R. Gardiner, M. Lavin, 2008, British Journal of Cancer.

Consensus guidelines for reporting prostate cancer Gleason Grade

B. Delahunt, H. Samaratunga, J. Srigley, 2016, BJU international.

The current status of renal cell carcinoma and prostate carcinoma grading

B. Delahunt, H. Samaratunga, L. Egevad, 2018, International braz j urol : official journal of the Brazilian Society of Urology.

Artificial Intelligence for Diagnosis and Gleason Grading of Prostate Cancer in Biopsies-Current Status and Next Steps.

Po-Hsuan Cameron Chen, G. Litjens, P. Ruusuvuori, 2021, European urology focus.

Nodular fasciitis and related pseudosarcomatous lesions of soft tissues.

H. Samaratunga, J. Searle, B. O'Loughlin, 1996, The Australian and New Zealand journal of surgery.

Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma.

H. Samaratunga, G. Gobe, S. Wood, 2019, Translational andrology and urology.

Intravascular Fasciitis: A case report and review of the literature

H. Samaratunga, J. Searle, Barry O'Loughlin, 1996, Pathology.

Low‐grade prostate cancer should still be labelled cancer

B. Delahunt, D. Berney, D. Bostwick, 2022, BJU international.

Utility of Pathology Imagebase for standardisation of prostate cancer grading

Toyonori Tsuzuki, Lars Egevad, Murali Varma, 2018, Histopathology.

Use of a trizonal schema to assess targeting accuracy in prostatic fusion biopsy

H. Samaratunga, J. Yaxley, G. Coughlin, 2020, BJU international.

Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function

H. Samaratunga, J. Clements, N. Matigian, 2008, Biological chemistry.

Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading

P. Ström, H. Olsson, B. Delahunt, 2020, Virchows Archiv.

Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers

H. Samaratunga, H. Schirra, J. Yaxley, 2016, Prostate international.

Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer

H. Samaratunga, H. Schirra, J. Yaxley, 2015, The Prostate.

Prostate cancer grading, time to go back to the future

B. Delahunt, D. Bostwick, A. Evans, 2020, BJU international.

Evolution, controversies and the future of prostate cancer grading

B. Delahunt, H. Samaratunga, L. Egevad, 2019, Pathology international.

From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer

B. Delahunt, H. Samaratunga, J. Srigley, 2016, Scandinavian journal of urology.

Late recurrence of renal solitary fibrous tumour in the contralateral kidney.

B. Delahunt, H. Samaratunga, L. Egevad, 2022, Pathology.

One is the new six: The International Society of Urological Pathology (ISUP) patient-focused approach to Gleason grading.

B. Delahunt, A. Evans, H. Samaratunga, 2016, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma.

T. H. van der Kwast, H. Samaratunga, M. Varma, 2021, European urology focus.

Significance of stromal reaction patterns in invasive urothelial carcinoma.

H. Samaratunga, D. Purdie, Peta Fairweather, 2005, American journal of clinical pathology.

ATYPICAL PRESENTATION OF HERPES SIMPLEX (CHRONIC HYPERTROPHIC HERPES) IN A PATIENT WITH HIV INFECTION

H. Samaratunga, D. Weedon, N. Musgrave, 2001, Pathology.

Histological comparison between predictive value of preoperative 3‐T multiparametric MRI and 68Ga‐PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer

B. Delahunt, H. Samaratunga, L. Egevad, 2020, BJU international.

Gleason scoring: a comparison of classical and modified (International Society of Urological Pathology) criteria using nadir PSA as a clinical end point

B. Delahunt, H. Samaratunga, J. Srigley, 2010, Pathology.

Oncological and urinary outcomes following low‐dose‐rate brachytherapy with a median follow‐up of 11.8 years

B. Delahunt, H. Samaratunga, L. Egevad, 2022, BJU international.

Design and Clinical Verification of Surface-Enhanced Raman Spectroscopy Diagnostic Technology for Individual Cancer Risk Prediction.

Jing Wang, Matt Trau, Robert A Gardiner, 2018, ACS nano.

Loss of Heterozygosity at the BRCA 2 Locus Detected byMultiplex Ligation-Dependent ProbeAmplification is Common in Prostate Cancers fromMenwith a Germline BRCA 2 Mutation

H. Samaratunga, J. Hopper, S. Dawson, 2008 .

Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography.

H. Samaratunga, M. Heymans, P. Stricker, 2023, European urology oncology.

External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter Study.

H. G. van der Poel, H. Samaratunga, J. Yaxley, 2021, European urology.

Premalignant lesions of the urinary bladder.

B. Delahunt, H. Samaratunga, L. Egevad, 2013, Pathology.

Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System.

B. Delahunt, A. Evans, D. Grignon, 2017, Archives of pathology & laboratory medicine.

Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial

B. Delahunt, H. Samaratunga, L. Egevad, 2021, Pathology.

Intraductal Carcinoma of the Prostate and Nuclear Size.

B. Delahunt, H. Samaratunga, L. Egevad, 2022, The American journal of surgical pathology.

Intraductal carcinoma of the prostate is not a diagnostic entity

B. Delahunt, J. Kench, T. H. van der Kwast, 2020, Histopathology.

Prostate-specific Antigen (PSA) and Cancer-Associated Serum Antigen (CASA) in Distinguishing Benign and Malignant Prostate Disease

H. Samaratunga, M. McGuckin, M. Walsh, 1995, The International journal of biological markers.

Long‐term outcomes of high‐dose‐rate brachytherapy for intermediate‐ and high‐risk prostate cancer with a median follow‐up of 10 years

H. Samaratunga, R. Gardiner, J. Yaxley, 2017, BJU international.

Expression of PSA-RP2, an alternatively spliced variant from the PSA gene, is increased in prostate cancer tissues but the protein is not secreted from prostate cancer cells

Robert Gardiner, H. Samaratunga, J. Clements, 2010, Biological chemistry.

Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study.

B. Delahunt, H. Samaratunga, L. Egevad, 2017, Pathology.

The decline of medical publishing: the rise of the pseudo-journal.

B. Delahunt, H. Samaratunga, L. Egevad, 2017, Pathology.

Detection of perineural invasion in prostate needle biopsies with deep neural networks pdf

Pekka Ruusuvuori, Martin Eklund, Lars Egevad, 2020, Virchows Archiv.

Utility of Reporting the Percentage of High-grade Prostate Cancer.

B. Delahunt, H. Samaratunga, J. Srigley, 2016, European urology.

Recent advances in urological pathology.

H. Samaratunga, L. Egevad, J. Eble, 2020, Pathology (Sydney).

Findings in 1123 Men with Pre-operative 68Ga-PSMA PET/CT and mpMRI Compared to Totally Embedded Radical Prostatectomy Histopathology. Implications for the Diagnosis and Management of Prostate Cancer.

B. Delahunt, H. Samaratunga, L. Egevad, 2021, The Journal of urology.

Gleason and Fuhrman no longer make the grade

B. Delahunt, H. Samaratunga, J. Srigley, 2016, Histopathology.

Is the UICC/AJCC pT2 Staging Category for Clear Cell Renal Cell Carcinoma Meaningful?

B. Delahunt, H. Samaratunga, M. Varma, 2019, The American journal of surgical pathology.

Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma.

B. Delahunt, H. Samaratunga, M. Varma, 2019, Pathology.

Clinicopathologic Significance of Anterior Prostate Cancer

B. Delahunt, H. Samaratunga, L. Egevad, 2023, The American journal of surgical pathology.

Clinical significance of cancer in radical prostatectomy specimens: analysis from a contemporary series of 2900 men

B. Delahunt, H. Samaratunga, J. Srigley, 2014, Pathology.

Atypical prostatic glandular proliferations on needle biopsy: Diagnostic implications, use of immunohistochemistry, and clinical significance.

H. Samaratunga, R. Gardiner, J. Yaxley, 2006, Analytical and quantitative cytology and histology.

Two-dimensional correlated spectroscopy distinguishes clear cell renal cell carcinoma from other kidney neoplasms and non-cancer kidney

H. Samaratunga, G. Galloway, C. Mountford, 2021, Translational Andrology and Urology.

Prostate specific membrane antigen (PSMA) expression in vena cava tumour thrombi of clear cell renal cell carcinoma suggests a role for PSMA-driven tumour neoangiogenesis.

H. Samaratunga, G. Gobe, S. Wood, 2019, Translational andrology and urology.

[Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations].

J. Cheville, B. Delahunt, D. Grignon, 2014, Annales de pathologie.

The emerging role of artificial intelligence in the reporting of prostate pathology.

P. Ruusuvuori, B. Delahunt, H. Samaratunga, 2021, Pathology.

International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2

T. H. van der Kwast, H. Samaratunga, M. Varma, 2023, The American journal of surgical pathology.

A progress report on a prospective randomised trial of open and robotic prostatectomy.

H. Samaratunga, S. Chambers, S. Occhipinti, 2014, European urology.

Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1

J. Logan, B. Delahunt, H. Samaratunga, 2023, Cancers.

Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000–2012

Pär Stattin, David Robinson, Brett Delahunt, 2017, BJU international.

Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management

H. Samaratunga, C. Magi-Galluzzi, E. Klein, 2010, BJU international.

Somatic alterations detected in diagnostic prostate biopsies provide an inadequate representation of multifocal prostate cancer

B. Delahunt, H. Samaratunga, J. Lindberg, 2019 .

Pathologist-Level Grading of Prostate Biopsies with Artificial Intelligence pdf

Ming Zhou, Toyonori Tsuzuki, Pekka Ruusuvuori, 2019, ArXiv.

ISUP Consensus Definition of Cribriform Pattern Prostate Cancer

B. Delahunt, D. Berney, A. Evans, 2021, The American journal of surgical pathology.

Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.007: Should Chromophobe Renal Cell Carcinom

B. Delahunt, H. Samaratunga, L. Egevad, 2021, European Urology.

Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol.

H. Samaratunga, S. Chambers, H. Schirra, 2016, Contemporary clinical trials.

Risk of metastatic disease on 68 Ga-PSMA PET/CT scan for primary staging of 1253 men at the diagnosis of prostate cancer.

H. Samaratunga, J. Yaxley, F. Nouhaud, 2019, BJU International.

Significance of minute focus of adenocarcinoma on prostate needle biopsy.

H. Samaratunga, J. Yaxley, K. Kerr, 2007, Urology.

Pathology Imagebase—a reference image database for standardization of pathology

Lars Egevad, Mark Clements, James G Kench, 2017, Histopathology.

Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread.

B. Delahunt, H. Samaratunga, L. Karageorgos, 2023, Pathology (Sydney).

Prostate cancer grading: recent developments and future directions

B. Delahunt, D. Grignon, H. Samaratunga, 2016, BJU international.

The International Society of Urological Pathology Education web—a web-based system for training and testing of pathologists

Toyonori Tsuzuki, Lars Egevad, Mark Clements, 2019, Virchows Archiv.

M. Rubin, A. Chinnaiyan, B. Delahunt, 2014, Archives of pathology & laboratory medicine.

Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques

B. Delahunt, H. Samaratunga, J. Srigley, 2017, World Journal of Urology.

From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer

B. Delahunt, H. Samaratunga, J. Srigley, 2016, Scandinavian journal of urology.

The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer

B. Delahunt, H. Samaratunga, L. Egevad, 2015, Pathology.

Optimising pre-analytical factors affecting quality of prostate biopsies: the case for site specific labelling and single core submission.

B. Delahunt, A. Evans, H. Samaratunga, 2014, Pathology.

Fuhrman grading is inappropriate for papillary renal cell carcinoma

B. Delahunt, H. Samaratunga, J. Srigley, 2018, World Journal of Urology.

Erratum: A working group classification of focal prostate atrophy lesions (American Journal of Surgical Pathology (2006) 30 (1281-1291))

Ximing J. Yang, M. Loda, R. Shah, 2006 .

Squamous cell carcinoma arising in a case of vulvitis granulomatosa or vulval variant of Melkersson-Rosenthal syndrome.

H. Samaratunga, G. Strutton, B. Hill, 1991, Gynecologic Oncology.

Isovalerylglycine and α-Ketobutyrate are novel biomarkers that discriminate clear cell renal cell carcinoma in biopsy specimens using two-dimensional magnetic resonance spectroscopy

H. Samaratunga, G. Galloway, C. Mountford, 2023, Advances in Biomarker Sciences and Technology.

Design and Clinical Verification of Surface-Enhanced Raman Spectroscopy Diagnostic Technology for Individual Cancer Risk Prediction.

K. M. Koo, H. Samaratunga, J. Yaxley, 2018, ACS nano.

Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading

P. Ström, H. Olsson, B. Delahunt, 2020, Virchows Archiv.

International Society of Urological Pathology (ISUP) grading of prostate cancer – An ISUP consensus on contemporary grading

B. Delahunt, H. Samaratunga, J. Srigley, 2016, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Distribution pattern of basal cells detected by cytokeratin 34 beta E12 in primary prostatic duct adenocarcinoma.

H. Samaratunga, M. Singh, 1997, The American journal of surgical pathology.